Do We Need Arguments Concerning What is Better, Sartans or ACE Inhibitors? (Part 2)
This paper is a review of the literature data on the impact of angiotensin II receptor blockers on the incidence of cardiovascular events. We compared their efficacy in the prevention of complications with angiotensin-converting enzyme inhibitors. The comparison of tolerability and safety of angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors use is being carried out. Conclusions were made that there is no significant difference, that would have clinical significance, between angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors.